Tag: Trump administration

  • More Laid-Off Employees Will Have To Pass Drug Test For Unemployment Benefits

    More Laid-Off Employees Will Have To Pass Drug Test For Unemployment Benefits

    The law goes into effect on November 4, 2019.

    More laid-off workers will have to take drug tests in order to qualify for unemployment benefits under a new rule passed by the Department of Labor on October 4.

    Vox reported that the ruling reversed the Obama administration’s 2016 limits on drug testing for unemployment. This new rule would allow states to test all laid-off employees who worked for companies that required a drug test in order to be hired for a job.

    Those that do not pass tests for marijuana, opioids or, as Vox noted, “any other class of illegal (and in some states, legal) substances,” would be denied unemployment benefits.

    Workers’ rights and civil rights advocates, as well as a few employers, have decried the decision—which some described as discriminatory and punitive towards unemployed Americans—while also questioning the need for expanded drug testing at a time when not only national unemployment rates but also the number of new unemployment claims were at historical lows.

    Obama-Era Amendment Gets Revoked

    The Obama-era law, which was established as an amendment of the Middle Class Tax Relief and Job Creation Act of 2012, restricted states’ ability to impose drug testing for unemployment benefits to employees in high-risk jobs, such as law enforcement, or to employees who were fired for testing positive for drugs. Republicans revoked the amendment shortly after Donald Trump took office as president; the new law will require all laid-off employees to submit to drug testing.

    The Department of Labor said that the decision, which goes into effect on November 4, was based on states’ rights, but as Vox noted, the move could be seen as a boon for companies, which would have to pay less unemployment insurance through the payroll tax.

    Critics Of The Ruling Speak Out

    Response to the ruling among workers’ rights groups and civil rights organization was largely negative.

    “This final rule represents a not-so-subtle attack on the character of unemployed Americans,” Michele Evermore, a policy analyst at the National Employment Law Project, told Vox. “Drug testing is simply a lazy way of blaming the victims of larger economic trends or corporate practices such as downsizing, outsourcing, and offshoring.”

    Some employers also voiced opposition to the decision. “Testing someone that is attempting to collect on the benefits they rightfully deserve seems out of line,” wrote John Beebe, a truck and auto service company owner, on the comments page for Regulations.gov. “We should be supporting and helping them return to the work force.”

    Vox also noted that low rates for both unemployment and applications for unemployment benefits largely negate the need for stricter requirements. The U.S. jobless rate reached a 49-year low of 3.6% in April 2019 while adding more than 260,000 jobs, while 192,000 individuals applied for benefits during the second week of April, the lowest since September 1969.

    View the original article at thefix.com

  • Trump Says Ketamine Derivative Can Help Veterans With Depression

    Trump Says Ketamine Derivative Can Help Veterans With Depression

    Trump recently told reporters that he has instructed “top officials” at the VA to order esketamine.

    President Donald Trump ordered the Department of Veterans Affairs (VA) to purchase a large amount of a ketamine derivative as a means of combating rising suicide rates among military veterans.

    While en route to a veterans’ conference in Kentucky, Trump told reporters that he has instructed “top officials” at the VA to order esketamine, a medically viable variation of ketamine in nasal spray form that has been approved by the Food and Drug Administration (FDA) for treatment of depression.

    Trump’s Request

    Trump’s request countered a decision by the VA’s medical board to exclude esketamine from the list of drugs in its hospital system, save for extreme cases without results from any other medication.

    Trump told reporters that esketamine—which is marketed under the brand name Spravato by troubled pharmaceutical company Johnson & Johnson—has had a “tremendously positive” effect in tests involving patients with depression.

    However, as The Atlantic noted, test results produced a very different result, with just one of three clinical trials showing any benefit. And though approved for use by the FDA, the agency’s support hinged on using the drug with an oral antidepressant, and only in cases of severe depression that have not shown response from other treatments. The FDA even published a report in mid-August 2019—a week before the president’s statement—that viewed esketamine as less reliable than a placebo.

    The VA’s Stance

    The VA did not comment on its decision to exclude esketamine from its drug supply in 2019, but did note that it would be available for “occasional use” in extreme cases of depression. The president’s comments did not appear to change that stance: spokesperson Susan Carter told The Atlantic that it will “closely monitor” esketamine use in veterans and may consider revising its guidelines “if warranted.”

    Ketamine—an anesthesia medication used to assist sedatives and painkillers in cases of surgery or major injuries—is also known as a recreational drug for its hallucinogenic properties. More recently, the drug has been put forward as treatment for a host of mental disorders, including treatment-resistant depression, obsessive-compulsive disorder and post-traumatic stress disorder. Though small clinical trials have yielded some positive results, others have shown that ketamine’s effectiveness as a depression treatment is limited.

    View the original article at thefix.com

  • Trump Administration May Remove Privacy Rules For Patients With Addiction History

    Trump Administration May Remove Privacy Rules For Patients With Addiction History

    Relaxing privacy rules about patients’ addiction histories could save lives, the administration argues.

    The Trump administration could soon weaken patient privacy laws for people who have received treatment for addiction. The intent is to stop doctors and other types of treatment centers from unknowingly providing prescription pain pills or other addictive drugs to patients who have a history of addiction.

    The proposed change would let medical providers add addiction treatments into patients’ standard medical records. Health Secretary Alex Azar hopes to make changes to the rules because he believes they prevent doctors and other health care professionals from getting crucial information that patients themselves have already agreed to share.

    These regulations “serve as a barrier to safe, coordinated care for patients,” Azar argued. “The information is currently so tightly restricted that even with the patient’s consent to share information, some health care providers are unwilling to record needed information on a patient’s health or treatment.”

    Jessie’s Law

    To bolster his point, Azar pointed to Jessie’s Law, which gets its namesake from a patient named Jessica Grubb. She was prescribed oxycodone after knee surgery despite having told her doctors about her history of addiction and died from an overdose the night she was released from the hospital.

    Similar laws have been bandied about in the halls of Congress. Despite initial bipartisan support, the bills lost steam in the Senate.

    Avoiding Stigma

    Not everyone sees eye-to-eye with Azar’s point of view. Opioid abuse advocacy groups, such as the American Association for the Treatment of Opioid Dependence and the Legal Action Center, have voiced concerns regarding involuntarily including such information on patient medical records.

    In their view, some patients might dodge the much-needed treatments in order to avoid the heavy stigma that comes with addiction treatment. According to these groups, just 10% of Americans suffering from substance use disorder sought treatment last year, and that number could be even lower if such regulations were passed.

    But Azar’s camp remains unconvinced in the face of an increasingly concerning epidemic.

    “All of the changes that we are proposing still are premised on patient consent,” said Azar.

    Having this information be accessible is crucial “to determine whether a patient was receiving treatment for opioid use disorder,” Azar argued. “And that is information that could save a patient’s life.”

    View the original article at thefix.com

  • Trump Celebrates Overdose Death Decline, But Drug Policy Remains Chaotic 

    Trump Celebrates Overdose Death Decline, But Drug Policy Remains Chaotic 

    While the decline is a positive step, many remain concerned about drug research and the lack of leadership in the DEA.

    President Trump is celebrating—and claiming credit for—the first drop in the overdose death rate in decades, but political insiders say that his White House remains unorganized, especially when it comes to drug policy. 

    During an event last month that highlighted the overdose death decline, Trump said, “This is a meeting on opioid[s] and the tremendous effect that’s taken place over the last little period of time.”

    “They’re going to make the political argument that they’re winning,” Regina LaBelle, Obama-era chief of staff for the Office of National Drug Control Policy (ONDCP), told STAT News. “Which they can say, since deaths are down. But I get concerned that we’re going to take our eye off the ball on the broader issue of addiction.”

    One major concern that some people have is that the Drug Enforcement Administration (DEA) remains without a leader. It’s been that way for more than two years, which Clinton-era “drug czar” General Barry McCaffrey finds absurd. 

    “The White House is so disorganized and dysfunctional that they can’t pluck an apple sitting at eye level in front of them,” he said. “Why wouldn’t you have a DEA administrator, for God’s sake? In 14 workdays, you could come up with a dozen superlative people with political chops who would take that job.”

    The Fight For Drug Research

    While the DEA does not have a leader, the agency finds itself at odds with other government agencies. On June 20, one DEA official asked Congress to classify all fentanyl analogues as Schedule I substances. The DEA has argued that this is necessary for law enforcement, but others, including a researcher from the National Institute on Drug Abuse (NIDA), say that this would inhibit research on opioids and treatment for opioid use disorder. 

    As part of the process, the DEA expressed its desire to control drug classifications without input from the Food and Drug Administration (FDA) and the NIDA.

    Senator Dick Durbin (D-Ill.) was so concerned by this power grab that he led a group of eight Senators (including one Republican) who authored a letter expressing their worries. 

    “We are concerned that the failure to engage necessary health experts vests far too much authority to a law-enforcement agency and may result in action that will deter valid, critical medical research aimed at responses to the opioid crisis,” the senators wrote. 

    Michael Collins, director of national affairs for the Drug Policy Alliance, said that the agency is “playing on people’s fear in order to make a power grab that predates the fentanyl crisis.”

    “We are being asked to give DEA control of the scheduling process and give up due process and allow more prosecutorial power—and give up researching these substances and potentially saving lives as a result of that research,” he said. 

    View the original article at thefix.com

  • Congressman To Trump: Commute Sentences For 16,000 Non-Violent Prisoners

    Congressman To Trump: Commute Sentences For 16,000 Non-Violent Prisoners

    “Justice delayed is justice denied. Please do the right thing,” Democratic Congressman Steve Cohen wrote in his letter to Trump. 

    Steve Cohen, the Democratic Congressman from Tennessee’s 9th District, sent a tartly worded letter to President Donald Trump recommending that he commute the prison sentences of approximately 16,000 non-violent drug offenders.

    In the letter, Cohen wrote that he was inspired to send the request after Trump commuted the life sentence of Tennessee resident Alice Marie Johnson in 2018, and added that many other individuals currently behind bars “deserve the same relief.”

    Cohen’s letter referenced the efforts of reality television star Kim Kardashian in bringing Johnson’s sentence to Trump’s attention; Kardashian met with the president in May 2018 to discuss prison reform and the possibility of commutation for Johnson, a non-violent drug offender who had been sentenced to life in prison without chance of parole for her involvement in a drug trafficking scheme.

    Trump Has Granted Three Commutations During His Term

    After serving 21 years of her sentence, Trump granted Johnson’s petition for clemency on June 6, which marked the first of three such commutations since he took office.

    “Thousands serving time for non-violent drug offenses don’t have Kim Kardashian to plead their cases for clemency but are just as deserving of the relief,” wrote Cohen. “These non-violent drug offenders should be released based on their records, not on celebrity endorsements.”

    Cohen also noted that Trump’s predecessor, President Barack Obama, had established a clemency initiative in his second term in office that ultimately resulted in the commutation of more than 1,700 federal inmates, the majority of which had been convicted of non-violent drug offenses, according to Marijuana Moment.

    “Justice delayed is justice denied,” Cohen wrote in the conclusion of his letter. “Please do the right thing.”

    Cohen’s letter to the president comes on the heels of an announcement by Senator Cory Booker (D-NJ), who on June 20 detailed his “Restorative Justice Initiative” as part of his campaign for president.

    Cory Booker Makes Campaign Promise To Non-Violent Offenders

    As Marijuana Moment noted, Booker announced that if elected, he would grant clemency to an estimated 17,000 federal prisoners serving sentences for non-violent drug offenses. Approximately half of those individuals would have marijuana-related convictions.

    “Granting clemency won’t repair all the damage that has been done by the War on Drugs and our broken criminal justice system, but it will help our country confront this injustice and begin to heal,” he wrote. 

    Fellow Democratic presidential candidate Amy Klobuchar has also made clemency part of her campaign, and has suggested the establishment of a bipartisan clemency board to review and recommend non-violent cases to the president in a more expedient fashion. 

    View the original article at thefix.com

  • Trump On Opioid Epidemic: We're Making Tremendous Progress

    Trump On Opioid Epidemic: We're Making Tremendous Progress

    Trump discussed the opioid epidemic and addiction treatment funding during the Rx Drug Abuse & Heroin Summit.

    This week, the Rx Drug Abuse & Heroin Summit convened in Atlanta, Georgia. The annual summit (April 22-25) is attended by everyone who has a stake in the national drug crisis—people from the mental health field, law enforcement, health care, government, research and people in recovery.

    Among this year’s speakers are James Carroll, the director of the Office of National Drug Control Policy, and Dr. Nora Volkow, director of the National Institute on Drug Abuse. President Barack Obama and Patrick Kennedy have also attended the conference in years past.

    On the third day of the summit (April 24), Donald Trump and First Lady Melania came to address the summit.

    “Everyone here today is united by the same vital goal—to liberate our fellow Americans from the grip of drug addiction and to end the opioid crisis once and for all. It’s happening. It’s happening,” said Trump.

    The president outlined his administration’s efforts to mitigate the crisis thus far.

    “My administration is deploying every resource at our disposal to empower you, to support you and fight right by your side, and that’s what we’re doing,” he said.

    Trump cited the unprecedented amount of funding dedicated to fighting the opioid crisis under his administration—including a two-year plan to use $6 billion to fight opioid abuse—and didn’t hesitate to take credit for making “a tremendous amount of progress” in pushing back the deadly epidemic.

    “We have results that are unbelievable. Numbers that I heard, two weeks ago, that I was shocked to hear. We’re making tremendous progress,” he said.

    Naturally, the border wall was a highlight of Trump’s anti-drug plan. The president claimed that 90% of heroin is coming through the southern border, and said that construction is “probably ahead of schedule” on building “almost 400 miles of wall built by the end of next year.” The barrier will have a “tremendous impact on drugs coming into our country,” Trump promised. “You’re going to see some very, very big differences in the coming months.”

    Another feature of his plan to mitigate the painful effects of drug abuse across the U.S. was negotiating “a very big trade deal” with China—where “almost all fentanyl” comes from, according to the president—to prevent the synthetic opioid from being shipped to the U.S.

    In October 2017, Trump declared that the opioid crisis was a public health emergency.

    While he has brought attention to the national opioid crisis, critics aren’t convinced that the government’s anti-drug efforts have actually made a dent.

    View the original article at thefix.com

  • Celebs Petition Trump To Commute Sentence For Rapper Loon

    Celebs Petition Trump To Commute Sentence For Rapper Loon

    Grammy-winning singer Faith Evans, rapper Baby Bash and NBA All-Star Kevin Garnett are among the signees of the petition. 

    A contingent of entertainment industry figures is rallying around an effort to have President Donald Trump free a former hip-hop artist serving a 14-year prison sentence for heroin trafficking.

    Former Bad Boy recording artist, Loon, is the subject of a letter to Trump and petition filed by former music producer turned criminal justice advocate Weldon Angelos who served 13 of a 55-year sentence for firearm possession and charges related to marijuana trafficking, and who hopes that a presidential commutation of sentence could act as a “bridge building” effort between the White House and the entertainment industry.

    Among the letter’s signees are Grammy-winning singer Faith Evans, rapper Baby Bash, and Alice Johnson, whom Trump released from prison in 2018.

    Loon, who was born Chauncey Hawkins, earned a Top 10 album with his eponymous debut release for Bad Boy in 2003, and collaborated with label chief Sean “P. Diddy” Combs, Usher and Toni Braxton before parting ways with the music industry in 2008 and converting to Islam.

    As Amir Junaid Muhadith, he worked as a motivational speaker but was arrested in 2011 for his involvement with individuals operating a drug-trafficking ring in North Carolina. Having been convicted of two prior felonies, Loon declined to go to trial and accepted the 14-year sentence to avoid, in his words, “mandatory life in prison [with] no hopes of parole.”

    In the petition, Angelos cited Trump’s own statements about prison reform, including comments issued after the commutation of Alice Johnson’s sentence, in which the president said, “Those who have paid their debt to society and worked hard to better themselves while in prison deserve a second chance.”

    Johnson had served 21 years of a life sentence for conspiracy to possess cocaine and attempted possession of cocaine before Kim Kardashian West pled her case to the White House.

    Angelos also sees the commutation as an opportunity for Trump to forge a connection to the entertainment industry, which has, in many cases, kept him at arms’ length. “His case is like a bridge builder,” said Angelos. “Now we can bring entertainers to the White House who would disagree with Trump otherwise.”

    Angelos said that he plans to deliver the letter to the White House within the next three weeks. In addition to Evans, Baby Bash and Johnson, the public figures that have added their names to the letter include producers Stevie J., Kevin McCall and Michael Goldstein, rappers Freeway and Benzino; film producers Marc Levin and Scott Budnick; Roc-A-Fella Records co-founder Damon “Dame” Dash; former Minnesota Timberwolves/Boston Celtics great Kevin Garnett; and CAN-DO founder Amy Povah.

    View the original article at thefix.com

  • US Health Chief Announces Support For Needle Exchange Programs

    US Health Chief Announces Support For Needle Exchange Programs

    The Health Secretary’s reversal on needle exchange programs may be related to a new 2030 deadline related to HIV.

    Speaking at the National HIV Prevention Conference on Tuesday, Health and Human Services Secretary Alex Azar expressed support for needle exchange programs as a way to stop the spread of HIV.

    Republicans like Azar have largely resisted these programs, believing that they will encourage drug use—but evidence to the contrary appears to have convinced the HHS Secretary otherwise.

    “Syringe services programs aren’t necessarily the first thing that comes to mind when you think about a Republican health secretary, but we’re in a battle between sickness and health, between life and death,” Azar said during his speech according to The Hill. “The public health evidence for targeted interventions here is strong, and supporting communities when they need to use these tools means fewer infections and healthier lives for our fellow Americans.”

    Needle exchange programs have existed for years, but are as important as ever with the national opioid crisis. These programs have reduced the spread of dangerous viruses such as HIV and hepatitis C through intravenous drug use. The first such program in the U.S. was established in 1988 in Tacoma, Washington, and was rewarded with a 60% reduction in new hepatitis B and C cases.

    Studies over the decades have also consistently found that these services do not increase the number of intravenous drug users. At the same time, needle exchange programs cost significantly less than treating new cases of HIV and hepatitis.

    However, the larger Trump administration still opposes these programs as well as safe injection sites where individuals can use drugs without fear of arrest, and in the presence of medical professionals who both provide clean equipment and are ready to save lives in case of an overdose.

    In February, the Department of Justice sued Safehouse, a non-profit organization based in Philadelphia, to prevent them from opening the country’s first safe injection site.

    Azar’s reversal on needle exchange programs may be related to a new 2030 deadline related to HIV. Earlier this month, the Trump administration revealed its 2020 budget proposal, which included a request for $291 million for an ambitious plan to end the “HIV epidemic” in a decade.

    “For the first time in modern history, America has the ability to end the epidemic, with the availability of biomedical interventions such as antiretroviral therapy and pre-exposure prophylaxis (PrEP),” the budget plan reads.

    With Azar’s statements at the National HIV Prevention Conference, it appears that needle exchange programs could become a part of these efforts. Most of the $291 million requested will be given to the Centers for Disease Control and Prevention (CDC), which supports and helps to fund these services.

    View the original article at thefix.com

  • Melania Trump: Media Should Focus On Opioid Crisis, Not "Gossip"

    Melania Trump: Media Should Focus On Opioid Crisis, Not "Gossip"

    The First Lady addressed the opioid epidemic at a recent town hall meeting in Las Vegas. 

    First Lady Melania Trump called on the media this week to spend more time focusing on the opioid epidemic and less time on frivolous reporting. 

    “I challenge the press to devote as much time to the lives lost and the potential lives that could be saved by dedicating the same amount of coverage that you do to idle gossip or trivial stories,” she said during a town-hall meeting in Las Vegas on Tuesday (March 5).

    The meeting was part of a three-stop tour highlighting her “Be Best” campaign, which focuses on well-being for young people by touching on topics including the dangers of opioids, according to NBC News.

    The first lady continued, “I wish the media would talk about more and educate more children, also adults, parents, about the opioid crisis that we have in the United States. They do it already, but I think not enough.”

    Trump said that coverage of the opioid epidemic should focus on the human toll of drug addiction

    “When we see breaking news on TV, or the front pages of newspaper — it is my hope that it can be about how many lives we were able to save through education and honest dialogue,” she said. 

    In her own home, she warns her son Barron, 12, that “drugs are dangerous. It will mess up your head. It will mess up your body and nothing comes positive out of it,” according to Time.

    Mrs. Trump is focusing on the opioid epidemic as part of overall wellness for young people, and feels that education is a key component of that. 

    “As a mother and as first lady, it concerns me that in today’s fast-paced and ever-connected world, children can be less prepared to express or manage their emotions and oftentimes turn to forms of destructive or addictive behavior such as bullying, drug addiction or even suicide,” she said last year. “I feel strongly that as adults we can and should be best at educating our children about the importance of a healthy and balanced life.”

    At the Las Vegas event Trump spoke with Eric Bolling, a former anchor for Fox News. Bolling’s son Eric died at 19 from a drug overdose, and Bolling has spoken publicly about the loss, including in a White House video

    “We never saw it coming,” Bolling said. “We never thought we would get that call.”

    In the video Bolling emotionally warns parents that they need to be aware that anyone’s child can fall victim to opioids. 

    “Not-my-kid syndrome is a killer. Because you just don’t know. It could very well be your kid,” he said. “So do us all a favor. Do yourself a favor. Do your family a favor. Do your children a favor. Have the discussion with them and do it again. And again. Get involved in your kids lives. …You could save a life. “

    View the original article at thefix.com

  • Trump Donates $100,000 To Alcoholism Research

    Trump Donates $100,000 To Alcoholism Research

    The president committed to donating his annual $400,000 salary to worthy causes as part of his 2016 campaign.

    President Donald Trump has donated $100,000 to the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a federal agency and branch of the National Institutes of Health.

    The $100,000 comes from his $400,000 yearly salary as president, which he promised to donate to worthy causes as part of his 2016 campaign. He has so far given away $100,00 each quarter to government departments including Veterans Affairs, the Small Business Administration, and the National Park Service.

    Alcoholism has touched the president personally. His brother, Fred Trump Jr., died from complications related to alcoholism in 1981 at the age of 43. According to Donald Trump, Fred advised him to never drink, and the president has repeatedly expressed his distaste for alcohol and drinking.

    Following the Senate Judiciary Committee hearings to examine the sexual assault accusation against Supreme Court Justice Brett Kavanaugh, Trump expressed that he did not share Kavanaugh’s passion for beer.

    “I don’t drink beer,” Trump told reporters. “I’ve never had a beer. And I’m not saying good or bad, some people like it. I just choose not to do that for a lot of reasons.”

    An individual “close to the White House” also told The Washington Post that the president “doesn’t like drinkers.” Tony Schwartz, co-author of Trump’s memoir The Art of the Deal, has said that the main reason the president avoids alcohol is a fear of losing control.

    “One of the primary reasons I think Trump avoided alcohol was that he never wanted to be out of control,” said Schwartz. “It made him feel weak and vulnerable in any circumstance where he felt that was the risk.”

    Alcohol is known to lower inhibitions when consumed to intoxication.

    On the other hand, Tim O’Brien, author of TrumpNation, believed that Fred Trump’s alcoholism and early death had a significant effect on the president and his aversion to drinking.

    “I think he’s scared of the effects alcohol can have on people because he witnessed firsthand how it destroyed his brother’s life, and I think he’s a teetotaler because he’s scared of it in himself,” said O’Brien. 

    “I think Freddy’s journey sparks fear in the president, and it’s a tragedy in their family’s history, and both of those things make him very uncomfortable around people with a drinking problem.”

    According to the NIAAA, 15.1 million adults in the U.S. had alcohol use disorder in 2015, and there are 88,000 alcohol-related deaths yearly. Alcohol use and misuse is one of the leading causes of preventable death.

    View the original article at thefix.com